funder logo

NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA

NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA

Minneapolis, MN, US
501(c)3
EIN
26-0636598
Fund Raising & Fund Distribution
funder logo

NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA

Minneapolis, MN, US
501(c)3
EIN
26-0636598
Fund Raising & Fund Distribution

Overview

Sign up for

Est.

2007

Fiscal Year Start

Jul 1

Organization Type

funder logo
Grantmaker

AI Summary

The National Institute for Pharmaceutical Technology and Education is a 501(c)(3) organization that focuses on advancing pharmaceutical technology through strategic grantmaking. In the filing year 2024, the organization awarded a total of $2.9 million across 13 grantees, operating on a relationship-based, invitation-only model. It does not accept unsolicited proposals; however, nonprofits can explore warm-introduction pathways through Impala's Funder Prospecting to engage with this funder.

Mission Statement

The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.
Total Funding Given

$2.9M

2024
Grantees funded
13
Multi-year grantees
54%
Funding by Year
Evaluate your own portfolio
Understand the health of your own grantees and uncover signs of risk.
plg-image
plg-image
Evaluate your own portfolio
Understand the health of your own grantees and uncover signs of risk.
Total No. of Grants

10

Median 1st year grant
$119.3K
Median 2nd year grant
$143.7K
E
Eric L Barker
Board Member
M
Martin S Zand
Board Member
A
Alberto Cuitino
Board Member

Frequently Asked Questions

Can I submit an unsolicited grant proposal to NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA?
No. NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA does not accept unsolicited proposals. Funding is by invitation only.
Where does NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA give?
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA primarily gives to organizations located in New Jersey, Minnesota, and Virginia. These states represent the largest share of the foundation’s grantmaking by dollars awarded. Additional geographic details are available to registered users.
What size are NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA’s grants?
The largest share of grants from NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA fall in the $250 thousand to $500 thousand range. The median first-year grant is about $119 thousand. More detailed grant size data is available to registered users.
How many grants does NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA make each year?
In 2024, NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA awarded about 10 grants, totaling nearly $2.9 million. More detailed grant metrics are available to registered users.
Who did NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA fund recently?
In 2024, NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA awarded grants to about 10 grantees. Recent grantees include RUTGERS THE STATE UNIVERSITY OF NJ, PURDUE UNIVERSITY, and REGENTS OF THE UNIVERSITY OF MINNESOTA. More detailed information on all recent recipients is available to registered users.
How do we apply to NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA?
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA does not accept unsolicited proposals. Funding is by invitation only.
Overview
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)